Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
25.69
+1.33 (5.46%)
At close: Aug 20, 2025, 4:00 PM
26.05
+0.36 (1.40%)
Pre-market: Aug 21, 2025, 6:25 AM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $2.89 billion as of August 21, 2025. Its market cap has decreased by -50.85% in one year.
Market Cap
2.89B
Enterprise Value
2.08B
1-Year Change
-50.85%
Ranking
Category
Stock Price
$25.69
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $2.89B, an increase of 3,627.37%. That is a compound annual growth rate of 42.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 2.74B | -38.91% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.28B |
| Johnson & Johnson | 427.82B |
| AbbVie | 364.58B |
| UnitedHealth Group | 273.15B |
| AstraZeneca | 246.07B |
| Novo Nordisk | 241.43B |
| Novartis AG | 240.40B |
| Abbott Laboratories | 228.87B |